1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
Follow Open-angle Glaucoma: new trials by email Literature Review of Open-angle Glaucoma trials Research Report on Open-angle Glaucoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes Bimatoprost Ophthalmic Solution, 0.01%, LUMIGANĀ® (bimatoprost ophthalmic solution) 0.01% - Open-angle Glaucoma, Ocular Hypertension | Phase 1 | Unknown | Amneal Pharmaceuticals, LLC | 240 | 2024-04-01 | 2024-08-06 |
Glaucoma, Open-Angle (1) · Ocular Hypertension (1)
Eye Diseases (1) · Glaucoma (1)
Bimatoprost (1)
Amneal Pharmaceuticals, LLC (1)
United States (1)